Skip to content

Clinical trials

Completed Phase 3 Eye Diseases trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Eye Diseases Phase: Phase 3 Status: Completed Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20081
20103
20113
20131
20142
20162
20182
20192
20202
20213
20221
20234
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GenSight Biologics4
Novartis Pharmaceuticals4
Kodiak Sciences Inc3
LENZ Therapeutics, Inc3
Vanda Pharmaceuticals3
University of California, San Francisco2
Alcon Research1
Bayer1
Centre Hospitalier Intercommunal Creteil1
Corxel Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Eye Diseases29
Retinal Diseases10
Vision Disorders7
Nervous System Diseases6
Retinal Degeneration6
Blindness5
Macular Degeneration5
Eye Diseases, Hereditary4
Mitochondrial Diseases4
Myopia4

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.